PFG Investments LLC Purchases 1,903 Shares of JPMorgan Chase & Co. $JPM

PFG Investments LLC lifted its position in shares of JPMorgan Chase & Co. (NYSE:JPM) by 2.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 72,804 shares of the financial services provider’s stock after purchasing an additional 1,903 shares during the period. JPMorgan Chase & Co. accounts for 0.9% of PFG Investments LLC’s portfolio, making the stock its 21st largest holding. PFG Investments LLC’s holdings in JPMorgan Chase & Co. were worth $23,831,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the business. Timmons Wealth Management LLC bought a new stake in shares of JPMorgan Chase & Co. during the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of JPMorgan Chase & Co. during the 4th quarter worth $32,000. MBM Wealth Consultants LLC acquired a new stake in JPMorgan Chase & Co. during the first quarter worth about $29,000. Osbon Capital Management LLC acquired a new stake in shares of JPMorgan Chase & Co. during the 4th quarter worth approximately $35,000. Finally, Turning Point Benefit Group Inc. bought a new position in shares of JPMorgan Chase & Co. in the 3rd quarter valued at $35,000. 71.55% of the stock is owned by institutional investors and hedge funds.

Key JPMorgan Chase & Co. News

Here are the key news stories impacting JPMorgan Chase & Co. this week:

• Positive Sentiment: JPMorgan’s market-leading profitability and resilient earnings remain supportive. The bank recently reported earnings and revenue above consensus expectations, while analysts continue to project solid full-year earnings. JPMorgan Stock Falls as Treasury Yields Retreat
• Positive Sentiment: J.P. Morgan Life Sciences Private Capital appointed Bruce N. Rogers, Ph.D., as a venture partner, strengthening the firm’s specialist investment capabilities and potentially supporting long-term asset-management growth. J.P. Morgan Life Sciences Private Capital Appointment
• Neutral Sentiment: JPMorgan is reportedly among the lead underwriters arranging an expanded credit facility for Anthropic ahead of a potential IPO. The mandate could generate fees and reinforce JPMorgan’s investment-banking position, but it is unlikely to materially affect near-term earnings. Anthropic Pre-IPO Financing
• Neutral Sentiment: Articles continue to focus on succession risk after Jamie Dimon eventually steps down. His long tenure supports investor confidence, but the company’s scale and depth of management may limit the impact of any leadership transition. Jamie Dimon Succession Analysis
• Negative Sentiment: Retreating Treasury yields provided the clearest trading-related reason for JPMorgan’s weakness. Investors appear to be taking profits in the bank despite record earnings and strong trading revenue, while the stock’s proximity to its 52-week high may have increased sensitivity to selling. JPMorgan Stock Performance Analysis

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on JPM shares. Truist Financial lifted their price target on shares of JPMorgan Chase & Co. from $344.00 to $352.00 and gave the company a “hold” rating in a report on Wednesday, July 15th. Citigroup raised their price objective on JPMorgan Chase & Co. from $325.00 to $360.00 and gave the stock a “neutral” rating in a research report on Monday, July 20th. Evercore restated an “outperform” rating and issued a $360.00 target price on shares of JPMorgan Chase & Co. in a report on Monday, July 6th. Bank of America increased their price target on JPMorgan Chase & Co. from $408.00 to $420.00 and gave the stock a “buy” rating in a report on Thursday, July 16th. Finally, Zacks Research upgraded JPMorgan Chase & Co. from a “hold” rating to a “strong-buy” rating in a research note on Thursday, July 16th. One research analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating and eleven have assigned a Hold rating to the company’s stock. According to MarketBeat.com, JPMorgan Chase & Co. presently has an average rating of “Moderate Buy” and a consensus price target of $359.96.

JPMorgan Chase & Co. Price Performance

Shares of NYSE JPM opened at $357.38 on Thursday. The stock’s 50 day moving average price is $343.09 and its 200-day moving average price is $316.79. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 1.30. JPMorgan Chase & Co. has a twelve month low of $279.10 and a twelve month high of $366.50. The company has a market capitalization of $949.98 billion, a PE ratio of 15.31, a PEG ratio of 1.49 and a beta of 0.99.

JPMorgan Chase & Co. (NYSE:JPM) last announced its earnings results on Tuesday, July 14th. The financial services provider reported $6.14 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.59 by $0.55. The firm had revenue of $58.02 billion during the quarter, compared to analyst estimates of $50.72 billion. JPMorgan Chase & Co. had a return on equity of 18.23% and a net margin of 21.86%.The business’s revenue was up 27.7% compared to the same quarter last year. During the same period last year, the firm posted $4.96 EPS. On average, equities analysts anticipate that JPMorgan Chase & Co. will post 24.28 EPS for the current year.

Insiders Place Their Bets

In other JPMorgan Chase & Co. news, General Counsel Stacey Friedman sold 5,467 shares of the business’s stock in a transaction on Monday, June 22nd. The stock was sold at an average price of $330.73, for a total value of $1,808,100.91. Following the sale, the general counsel directly owned 40,961 shares in the company, valued at $13,547,031.53. The trade was a 11.78% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Robin Leopold sold 2,500 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $361.41, for a total value of $903,525.00. Following the completion of the sale, the insider owned 73,547 shares in the company, valued at $26,580,621.27. This represents a 3.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.41% of the company’s stock.

JPMorgan Chase & Co. Profile

JPMorgan Chase & Co (NYSE: JPM) is a diversified global financial services firm headquartered in New York City. The company provides a wide range of banking and financial products and services to consumers, small businesses, corporations, governments and institutional investors worldwide. Its operations span retail banking, commercial lending, investment banking, asset management, payments and card services, and treasury and securities services.

The firm’s principal business activities are organized across several core lines: Consumer & Community Banking, which offers deposit accounts, mortgages, auto loans, credit cards and branch and digital banking under the Chase brand; Corporate & Investment Banking, which provides capital markets, advisory, underwriting, trading and risk management services; Commercial Banking, delivering lending, treasury and capital solutions to middle-market and corporate clients; and Asset & Wealth Management, which offers investment management, private banking and retirement services to institutions and high-net-worth individuals.